Abstract:DNA-binding molecules that recognize specific sequences offer a high potential for the understanding of chromatin structure and associated biological processes in addition to their therapeutic potential, e.g. as positioning agents for validated anticancer drugs. A prerequisite for the development of DNA-binding molecules is the availability of appropriate methods to assess their binding properties quantitatively at the desired target sequence in the human genome. We have further developed a capture assay to assess triplex-forming oligonucleotide (TFO) binding efficiency quantitatively. This assay is based on bifunctional, psoralen and biotin-conjugated, TFOs and real-time PCR analysis. We have applied this novel quantification method to address two issues that are relevant for DNA-binding molecules. First, we have compared directly the extent of TFO-binding in three experimental settings with increasing similarity to the situation in vivo, i.e. naked genomic DNA, isolated cell nuclei, or whole cells. This comparison allows us to characterize factors that influence genomic triplex formation, e.g. chromosomal DNA organization or intracellular milieu. In isolated nuclei, the binding was threefold lower compared to naked DNA, consistent with a decreased target accessibility int he nucleosomal environment. Binding was detected in whole cells, indicating that the TFO enters the nucleus and binds to its target in intact cells in vivo, but the efficiency was decreased (tenfold) compared to nuclei. Secondly, we applied the method to characterize the binding properties of two different TFOs targeting the same sequence. We found that an antiparallel-binding GT-containing TFO bound more efficiently, but with less target sequence selectivity compared to a parallel-binding CU-containing TFO. Collectively, a sensitive method to characterize genomic triplex formation was described. This may be useful for the determination of factors driving TFO binding efficiency and, thus, may improve the usefulness of triplex-mediated gene targeting for studies of chromatin structure as well as for therapeutic antigene strategies.

NMR investigation of FOXO4-DNA interaction for discriminating target and non-target DNA sequences

NMR 1H, 13C, 15N backbone resonance assignments of 14-3-3ζ binding region of human FOXO3a (residues 1-284)

Broad profiling of DNA-binding transcription factor activities improves regulatory network construction in adult mouse tissues.

Cellular Context- and Protein Level-Dependent Interaction of Pluripotency Factor OCT4A with Multiple Octamer Motifs of the Same Target Gene

Mechanistic Insights into the Preference for Tandem Binding Sites in DNA Recognition by FOXM1

Dynamic Conformational Change Regulates the Protein-Dna Recognition: an Investigation on Binding of A Y-Family Polymerase to Its Target Dna

Mechanism of forkhead transcription factors binding to a novel palindromic DNA site

Structural Basis for DNA Recognition by FOXG1 and the Characterization of Disease-causing FOXG1 Mutations

Domain tethering impacts dimerization and DNA-mediated allostery in the human transcription factor FoxP1

Unraveling the folding and dimerization properties of the human FoxP subfamily of transcription factors

Toward a mechanistic understanding of DNA binding by forkhead transcription factors and its perturbation by pathogenic mutations

Comprehensive Interrogation of Natural TALE DNA-binding Modules and Transcriptional Repressor Domains

Characterization and quantification of triple helix formation in chromosomal DNA

Probing conformational dynamics of DNA binding by CO-sensing transcription factor, CooA

Identification of Transcription Factor-Binding Sites in the Mouse FOXO1 Promoter

Transcription dependence of chromosomal gene targeting by triplex-forming oligonucleotides

An Electrochemical Sensor for Oct4 Detection in Human Tissue Based on Target-Induced Steric Hindrance Effect on a Tetrahedral DNA Nanostructure.

Molecular mechanism of specific DNA sequence recognition by NRF1

Development of a FOXM1-DBD Binding Assay for High-Throughput Screening Using TR-FRET Assay

Guiding the pioneer

A Microfluidics-Based Platform For Identification And Detailed Characterization Of Transcription Factor Binding Sites